Mary M. Horowitz

National Marrow Donor Program — United States

Medicine · Health Sciences

128h-index56.6kcitations641works8.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(411), Acute Lymphoblastic Leukemia research(157), Acute Myeloid Leukemia Research(149), Chronic Myeloid Leukemia Treatments(75), Renal Transplantation Outcomes and Treatments(68)

Publications639 total

Mismatch Doesn't Mean Misfortune: Quality of Life after HCT in the ACCESS Trial
Transplantation and Cellular Therapy·2026Open Access
Trends in <scp>US</scp> Hematology/Oncology Physician Perceptions and Referral Practices for Hematopoietic Cell Transplant: A National Survey Conducted by <scp>NMDP</scp>
Cancer Medicine·2026Open Access
CHARM is prognostic of geriatric morbidity and toxicity after allogeneic transplant for older adults: BMT CTN 1704 study
Blood Advances·2025· 1 citedOpen Access
Secondary graft failure after PT-cy: Modeling a candidate risk assignment biomarker based on lymphocyte reconstitution.  Results from the BMT CTN 1801 study.
Blood·2025Open Access
Combined TCR-seq and single-cell RNA-seq reveal distinct origins for antiviral immunity after post-transplant cyclophosphamide and tac/MTX gvhd prophylaxis: Results from the BMT CTN 1801 study
Blood·2025
The feasibility of collecting social determinants of health in the national multi-center GRASP sickle cell gene therapy trial
Blood·2025
Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: BMT CTN 1702 Trial
Transplantation and Cellular Therapy·2025· 1 citedOpen Access
Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation
Journal of Clinical Oncology·2025· 3 citedOpen Access
Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries
UNC Libraries·2025Open Access
Correction: Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries
UNC Libraries·2025Open Access
Impact of transplant conditioning, <i>NPM1</i> mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia
Blood Advances·2025· 5 citedOpen Access
Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee
UNC Libraries·2025Open Access
Up-front alternative donor HCT in severe aplastic anemia: gaps and opportunities to translate evidence into practice
Blood Advances·2025· 2 citedOpen Access
Beyond maximum grade: tolerability of immunotherapies, cellular therapies, and targeted agents in haematological malignancies
The Lancet Haematology·2025· 5 citedOpen Access
Corrigendum to ‘Current Use and Trends in Hematopoietic Cell Transplantation in the United States’ [Transplantation and Cellular Therapy 26/8 (2020) e177-e182]
UNC Libraries·2025Open Access
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States
UNC Libraries·2025Open Access
Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703
Blood Advances·2025· 4 citedOpen Access
Accurate prediction of absolute prokaryotic abundance from DNA concentration
Cell Reports Methods·2025· 2 citedOpen Access
Novel composite health assessment risk model for older allogeneic transplant recipients: BMT-CTN 1704
Blood Advances·2025· 12 citedOpen Access
Haploidentical Bone Marrow Transplantation for Sickle Cell Disease
NEJM Evidence·2025· 23 citedOpen Access
page 1 of 32Next →

Frequent Co-authors

Daniel J. Weisdorf(14), Mary Eapen(11), Robert Peter Gale(11), Marcelo C. Pasquini(10), John P. Klein(10), Richard E. Champlin(9), Gèrard Socié(9), Kathleen A. Sobocinski(9), Stephen R. Spellman(8), J. Douglas Rizzo(8), Philip A. Rowlings(8), Stephanie J. Lee(7), H. Joachim Deeg(7), Dennis L. Confer(6), Joseph H. Antin(6), Hillard M. Lazarus(5), Aloïs Gratwohl(5), John M. Goldman(5), Sergio Giralt(5), Steven M. Devine(5)